Assessments for Emerging Pharmaceutics Top-Up Ranking “EPTUR” include the main four categories of clinical and market identifications to ensure the productions and APIs meet the direct essentials for adding in the list. “EPTUR” has the concentrative focus on emerging generic pharma productions based on the streamed  indicators as:



  • Generic Regulations Identification
  • Clinical Approval Identification
  • Brand Equity Strategy
  • Market Share Achievements (Local & Global)


By using the strategy of comprehensive evaluation of emerging generic pharmaceuticals, stakeholders and subscribers will use the facilities of collected, normalized and sorted data resource feeds of APIs beside of keeping in touch with the latest developments of emerging pharmaceuticals regulations and market brands.

The strategies of sorting and ranking the APIs strongly depend on sustaining the production and market dissemination features. Without a defined plan of presenting APIs, EPTUR can not warrant the recording, sorting and ranking them. A self-assessment survey by API suppliers must be submitted in advance for the internal reviewing and confirming the mandatory steps forward. Once hearing the approval of self-assessment process, A selected board of external advisers and experts will evaluate the API technical and commercial assignments and the decision will be made per case after a successful external evaluation. 

Technology-aimed Data Process and Analysis 

The process of data analysis through EPTUR uses Artificial Intelligence and Big Data compounded solutions to strength the integration of assigned data sources. Given the priorities and importance of streaming the assigned data in EPTUR, Both types of matrix-based and chart-based analytics are supported. 

International Scientific & Advisory Board Chair

Prof. Ting-Chao Chou

Chinese American theoretical biologist, pharmacologist, Thomson Reuters highly cited researcher and inventor. He is the Founder and President of PD Science LLC , USA.


How to participate in EPTUR and use its data observatory?

Either you are an API Supplier or an Individual Subscriber, EPTUR is a right choice for you to monitoring and tracking the emerging promotions in pharmaceutical brands in global markets. The live reports of the new sorted APIs make the most comprehensive features of the clinical and market evolution. As one of the most emphasized aims of EPTUR, 100 Top Emerging API Suppliers have the chance and opportunity to disseminate their productions through local and global networks of market targets as well as sharing the information to the main pharmaceutical market suppliers. Are there interests in getting in touch and hearing more about it? Just fill the contact form and one of our consultants will get in touch soon.

Contact with EPTUR Consultants and Receive More Information

Thank you for contacting us. Our consultants will get back to you as soon as possible.
Oops. An error occurred.
Click here to try again.